Structure |
Chemical Name |
CAS |
MF |
![Levofloxacin Impurity 9](/CAS/20180527/GIF/1797099-76-3.gif) |
Levofloxacin Impurity 9 |
1797099-76-3 |
C18H20FN3O4 |
![N-(5-Formyl-2-hydroxyphenyl)formamide](/CAS/20180527/GIF/903563-43-9.gif) |
N-(5-Formyl-2-hydroxyphenyl)formamide |
903563-43-9 |
C8H7NO3 |
![Nitrendipine Impurity 5](/) |
Nitrendipine Impurity 5 |
|
|
![Posaconazole Impurity 32](/) |
Posaconazole Impurity 32 |
|
|
![Posaconazole Impurity 61](/) |
Posaconazole Impurity 61 |
|
|
![Procaterol Impurity 4](/CAS/20200611/GIF/63235-39-2.gif) |
Procaterol Impurity 4 |
63235-39-2 |
C16H20N2O3 |
![Sitagliptin Impurity 14](/CAS/20211123/GIF/2072867-07-1.gif) |
Sitagliptin Impurity 14 |
2072867-07-1 |
C26H23F9N6O2 |
![SofosBuvir Impurity 31](/) |
SofosBuvir Impurity 31 |
|
|
![sofosBuvir Impurity 37](/) |
sofosBuvir Impurity 37 |
|
|
![SofosBuvir Impurity 53](/CAS/20210111/GIF/1015255-46-5.gif) |
SofosBuvir Impurity 53 |
1015255-46-5 |
C20H25FN3O9P |
![Sofosbuvir Impurity 60](/) |
Sofosbuvir Impurity 60 |
|
|
![Tenofovir impurity G](/) |
Tenofovir impurity G |
|
|
![Ticagrelor Impurity 26](/CAS/20200611/GIF/2245167-79-5.gif) |
Ticagrelor Impurity 26 |
2245167-79-5 |
C21H24F2N6O3S |
![Vildagliptin Impurity 19](/CAS/20180808/GIF/243145-00-8.gif) |
Vildagliptin Impurity 19 |
243145-00-8 |
C10H16N2O2 |
![Olopatadine Isopropyl ester Hydrochloride](/CAS/20180808/GIF/1206456-44-1.gif) |
Olopatadine Isopropyl ester Hydrochloride |
1206456-44-1 |
C24H29NO3 |
![GLATIRAMER impurity](/) |
GLATIRAMER impurity |
|
|
![Amoxicillin Impurity U](/CAS/20180629/GIF/CB23370032.gif) |
Amoxicillin Impurity U |
|
C16H19N3O5S |
![Amoxicillin Impurity U](/CAS/20180629/GIF/CB23370032.gif) |
Amoxicillin Impurity U |
|
C16H19N3O5S |
![5-HYDROXY LANSOPRAZOLE](/CAS/GIF/131926-98-2.gif) |
5-HYDROXY LANSOPRAZOLE |
131926-98-2 |
C16H14F3N3O3S |
![(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid](/CAS/20180702/GIF/CB22995779.gif) |
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
|
C22H23NO4 |
![Oxacillin Sodium Impurity I(EP)](/) |
Oxacillin Sodium Impurity I(EP) |
|
|
![Spectinomycin Impurity E](/) |
Spectinomycin Impurity E |
|
|
![3-butyl-3-hydroxy-2-benzofuran-1-one](/CAS/20180527/GIF/162050-42-2.gif) |
3-butyl-3-hydroxy-2-benzofuran-1-one |
162050-42-2 |
C12H14O3 |
![(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (minocycline)](/) |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (minocycline) |
|
|
![(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione](/CAS/20180527/GIF/2088771-61-1.gif) |
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione |
2088771-61-1 |
C16H13F6N5O2 |
![N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/20180629/GIF/1092578-45-4.gif) |
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
1092578-45-4 |
C20H25N5 |
![846023-56-1](/CAS/20200515/GIF/846023-56-1.gif) |
846023-56-1 |
846023-56-1 |
C26H31Cl2N5O4 |
![Prednisone impurity D (EP)](/CAS/20180527/GIF/10184-69-7.gif) |
Prednisone impurity D (EP) |
10184-69-7 |
C21H26O4 |
![Lisinopril EP Impurity G](/CAS/20180527/GIF/1356839-89-8.gif) |
Lisinopril EP Impurity G |
1356839-89-8 |
C42H60N6O9 |
![2-hexanoylbenzoic acid](/CAS/20180527/GIF/857538-11-5.gif) |
2-hexanoylbenzoic acid |
857538-11-5 |
C13H16O3 |
![Blonanserin N-Oxide](/CAS/20210111/GIF/142838-82-2.gif) |
Blonanserin N-Oxide |
142838-82-2 |
C23H30FN3O |
![Levofloxacin Impurity 11](/CAS/20180527/GIF/106939-42-8.gif) |
Levofloxacin Impurity 11 |
106939-42-8 |
C9H9F2NO |
![Rabeprazole Impurity 2](/CAS/20210111/GIF/1807988-36-8.gif) |
Rabeprazole Impurity 2 |
1807988-36-8 |
C18H19N3O4 |
![Tenofovir Related Compound 14](/CAS/20200611/GIF/1244022-52-3.gif) |
Tenofovir Related Compound 14 |
1244022-52-3 |
C8H11N5O |
![N-(2-methyl-5-nitrophenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide](/CAS/20180629/GIF/CB23382307.gif) |
N-(2-methyl-5-nitrophenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide |
|
C18H15N5O3 |
![N-(5-(benzyl(methyl)amino)-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide](/CAS/20180629/GIF/CB23382312.gif) |
N-(5-(benzyl(methyl)amino)-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide |
|
C25H23N5O |
![1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid](/CAS/20180527/GIF/956011-26-0.gif) |
1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid |
956011-26-0 |
C14H10FN3O2 |
![Nicorandil Impurity 4 Dinitrate](/CAS/20200515/GIF/1798026-96-6.gif) |
Nicorandil Impurity 4 Dinitrate |
1798026-96-6 |
C16H17N5O5 |
![WIXOVOWSUCEDGS-UHFFFAOYSA-N](/CAS/20180906/GIF/1346603-05-1.gif) |
WIXOVOWSUCEDGS-UHFFFAOYSA-N |
1346603-05-1 |
C15H20O5 |
![YXSRVOWUJUXDLJ-UHFFFAOYSA-N](/CAS/20210111/GIF/1618107-97-3.gif) |
YXSRVOWUJUXDLJ-UHFFFAOYSA-N |
1618107-97-3 |
C18H18FNO2S |
![S-2-Benzothiazolyl-2-amino-±-(methoxyimino)-4-thiazolethiolacetate](/CAS/20211123/GIF/1684396-27-7.gif) |
S-2-Benzothiazolyl-2-amino-±-(methoxyimino)-4-thiazolethiolacetate |
1684396-27-7 |
C13H10N4O2S3 |
![4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-CYCLOPENTENE-1-CARBOXYLIC ACID METHYL ESTER](/CAS/GIF/168683-02-1.gif) |
4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-CYCLOPENTENE-1-CARBOXYLIC ACID METHYL ESTER |
168683-02-1 |
C12H19NO4 |
![KNKJEUNXMFFFDU-LZHIOSKDSA-N](/CAS/20180808/GIF/138804-88-3.gif) |
KNKJEUNXMFFFDU-LZHIOSKDSA-N |
138804-88-3 |
C25H34O6 |
![MONO-DESACETYL FAMCICLOVIR](/CAS/GIF/104227-88-5.gif) |
MONO-DESACETYL FAMCICLOVIR |
104227-88-5 |
C12H17N5O3 |
![(E)-5-(2-CARBOXYVINYL)-2'-DEOXYURIDINE](/CAS/GIF/74131-06-9.gif) |
(E)-5-(2-CARBOXYVINYL)-2'-DEOXYURIDINE |
74131-06-9 |
C12H14N2O7 |
![HHUBRUYPYDODRB-UHFFFAOYSA-N](/CAS/20210111/GIF/106860-70-2.gif) |
HHUBRUYPYDODRB-UHFFFAOYSA-N |
106860-70-2 |
C8H5NO5 |
![5-Decyano 5-(Ethyl Formate) Milrinone](/CAS/20180808/GIF/80442-07-5.gif) |
5-Decyano 5-(Ethyl Formate) Milrinone |
80442-07-5 |
C14H14N2O3 |
![25-DESACETYL RIFAMPICIN](/CAS/GIF/16783-99-6.gif) |
25-DESACETYL RIFAMPICIN |
16783-99-6 |
C41H56N4O11 |
![ETHYL 2-CYCLOHEXYL-2-HYDROXY-PHENYLACETATE](/StructureFile/ChemBookStructure7/GIF/CB2372208.gif) |
ETHYL 2-CYCLOHEXYL-2-HYDROXY-PHENYLACETATE |
31197-69-0 |
C16H22O3 |
![1-(4-methoxyphenyl)-2-methylpropan-2-ol](/CAS/20180529/GIF/35144-39-9.gif) |
1-(4-methoxyphenyl)-2-methylpropan-2-ol |
35144-39-9 |
C11H16O2 |
![Apixaban Impurity 33](/CAS/20180629/GIF/1686149-78-9.gif) |
Apixaban Impurity 33 |
1686149-78-9 |
C21H27N3O3 |
![1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane](/CAS/20180629/GIF/414858-02-9.gif) |
1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane |
414858-02-9 |
C46H84N12 |
![butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/CAS/20180629/GIF/CB23956193.gif) |
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate |
2227199-31-5 |
C20H29N5O3 |
![ethyl 2-((E)-5-((E)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetate](/CAS/20180629/GIF/682775-71-9.gif) |
ethyl 2-((E)-5-((E)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetate |
682775-71-9 |
C17H17NO3S2 |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate](/CAS/20180702/GIF/CB22995784.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
![Ticagrelor Impurity N](/CAS/20200515/GIF/1643378-47-5.gif) |
Ticagrelor Impurity N |
1643378-47-5 |
C23H29FN6O4S |
![carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester](/CAS/20200331/GIF/929693-30-1.gif) |
carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester |
929693-30-1 |
C14H26N2O4 |
![Valaciclovir iMpurity](/) |
Valaciclovir iMpurity |
|
|
![Erlotinib hydrochloride Impurity C](/) |
Erlotinib hydrochloride Impurity C |
|
|
![Linagliptin Impurity B](/) |
Linagliptin Impurity B |
|
|
![Parecoxib Impurity A](/) |
Parecoxib Impurity A |
|
|
![Parecoxib Impurity F](/) |
Parecoxib Impurity F |
|
|
![2-(4-Benzhydrylpiperazino)ethyl acetoacetate](/CAS/20180702/GIF/89226-49-3.gif) |
2-(4-Benzhydrylpiperazino)ethyl acetoacetate |
89226-49-3 |
C23H28N2O3 |
![Axitinib Impurity a](/CAS/20200611/GIF/1347304-18-0.gif) |
Axitinib Impurity a |
1347304-18-0 |
C22H18N4O2S |
![Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)-](/CAS/20180702/GIF/132811-84-8.gif) |
Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)- |
132811-84-8 |
C21H26FN3 |
![Linagliptin Impurity W](/) |
Linagliptin Impurity W |
|
|
![(R)-4-fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile](/CAS/20180702/GIF/CB23042207.gif) |
(R)-4-fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C18H20FN5O2 |
![1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20180702/GIF/CB23049675.gif) |
1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C21H24FN3O4 |
![ethyl 1-cyclopropyl-7-fluoro-6,8-dimethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate](/CAS/20180702/GIF/CB23049680.gif) |
ethyl 1-cyclopropyl-7-fluoro-6,8-dimethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate |
|
C17H18FNO5 |
![Dapagliflozin Impurity 1](/) |
Dapagliflozin Impurity 1 |
|
|
![Ibrutinib Impurity 5](/) |
Ibrutinib Impurity 5 |
|
|
![Imatinib Impurity 4](/CAS/20210111/GIF/942514-62-7.gif) |
Imatinib Impurity 4 |
942514-62-7 |
C30H33N7O |
![Macitentan Impurity 2](/CAS/20211123/GIF/2211054-90-7.gif) |
Macitentan Impurity 2 |
2211054-90-7 |
C10H8Br2N4O2 |
![(R)-2-amino-4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl) phenyl)amino)-2-oxoethyl)thiazole 3-oxide](/CAS/20200331/GIF/1884646-38-1.gif) |
(R)-2-amino-4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl) phenyl)amino)-2-oxoethyl)thiazole 3-oxide |
1884646-38-1 |
C21H24N4O3S |
![Nilotinib Impurity 7](/CAS/20200611/GIF/2119583-26-3.gif) |
Nilotinib Impurity 7 |
2119583-26-3 |
C27H20F3N7O |
![Regorafenib Impurity 1](/) |
Regorafenib Impurity 1 |
|
|
![Regorafenib Impurity 6](/CAS/20180808/GIF/1187945-05-6.gif) |
Regorafenib Impurity 6 |
1187945-05-6 |
C20H12ClF4N3O4 |
![Sofosbuvir Impurity 9](/) |
Sofosbuvir Impurity 9 |
|
|
![Venlafaxine N-Oxide Impurity](/CAS/20180702/GIF/1021933-95-8.gif) |
Venlafaxine N-Oxide Impurity |
1021933-95-8 |
C16H25NO3 |
![Vonoprazan Impurity 4](/) |
Vonoprazan Impurity 4 |
|
|
![Vortioxetine Impurity 25](/CAS/20210111/GIF/1639263-80-1.gif) |
Vortioxetine Impurity 25 |
1639263-80-1 |
C18H22N2O2S |
![Cinacalcet Impurity B](/CAS/20211123/GIF/66469-40-7.gif) |
Cinacalcet Impurity B |
66469-40-7 |
C19H19N |
![Dapagliflozin Impurity D](/CAS/20211123/GIF/2133407-75-5.gif) |
Dapagliflozin Impurity D |
2133407-75-5 |
C21H25ClO6 |
![Escitalopram Impurity](/CAS/20210111/GIF/91283-87-3.gif) |
Escitalopram Impurity |
91283-87-3 |
C18H14FNO3 |
![Furosemide Imp.(EP)](/) |
Furosemide Imp.(EP) |
|
|
![Nifuratel Impurity](/CAS/20211123/GIF/167103-07-3.gif) |
Nifuratel Impurity |
167103-07-3 |
C6H5N3O4 |
![Vinpocetine Impurity](/CAS/20211123/GIF/102341-40-2.gif) |
Vinpocetine Impurity |
102341-40-2 |
C19H23N3O |
![2-amino-9-((1R,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one](/CAS/20180702/GIF/1367369-81-0.gif) |
2-amino-9-((1R,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-81-0 |
C12H15N5O3 |
![N-(3,4-dichlorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine](/CAS/20180702/GIF/CB23050741.gif) |
N-(3,4-dichlorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
2089650-13-3 |
C22H24Cl2N4O3 |
![Moxifloxacin Impurity 8](/) |
Moxifloxacin Impurity 8 |
|
|
![(3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid](/CAS/20180702/GIF/CB23052109.gif) |
(3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
|
C33H35FN2O5 |
![Olaparib Imp.2](/) |
Olaparib Imp.2 |
|
|
![Ciprofloxacin impurity I](/CAS/20180703/GIF/CB23054668.gif) |
Ciprofloxacin impurity I |
|
C17H18FN3O3 |
![5-(4'-((2-butyl-4-chloro-5-(isopropoxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole](/CAS/20180703/GIF/1332713-64-0.gif) |
5-(4'-((2-butyl-4-chloro-5-(isopropoxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole |
1332713-64-0 |
C25H29ClN6O |
![Afatinib Impurity L (Afatinib N-Oxide)](/) |
Afatinib Impurity L (Afatinib N-Oxide) |
|
|
![Afatinib Impurity L (Afatinib N-Oxide)](/) |
Afatinib Impurity L (Afatinib N-Oxide) |
|
|
![Mirabegron Deshydroxy](/CAS/20180808/GIF/1581284-82-3.gif) |
Mirabegron Deshydroxy |
1581284-82-3 |
C21H24N4OS |
![4-Thiazoleacetyl chloride, 2-amino-, monohydrochloride](/CAS/20180629/GIF/66313-72-2.gif) |
4-Thiazoleacetyl chloride, 2-amino-, monohydrochloride
|
66313-72-2 |
C5H6Cl2N2OS |
![1,2-bis(bromomethyl)-4,5-dimethoxybenzene](/CAS/20180703/GIF/26726-81-8.gif) |
1,2-bis(bromomethyl)-4,5-dimethoxybenzene |
26726-81-8 |
C10H12Br2O2 |
![Alvimopan Impurity 2](/) |
Alvimopan Impurity 2 |
|
|